The Effectiveness, Safety, and Cost-Reductions of an Intervention Bundle for Reducing Length of Stay in Laparoscopic Cholecystectomy Patients
Speaker(s)
Teo PSE1, Ouyang Y2, Fong XY1, Graves N2, Abdullah HR1
1Singapore General Hospital, Singapore, Singapore, 2Duke-NUS Medical School, Singapore, Singapore, Singapore
Presentation Documents
OBJECTIVES: A bundle of interventions was implemented for laparoscopic cholecystectomy (LC) in Singapore General Hospital to reduce post-operative length of stay (LoS). It was implemented in phases: a roadshow (RO) on 1st July 2020 to improve standardization of post-surgery care, default admissions to short-stay wards (SSW) from 1st March 2021 to reinforce LC as overnight-stay surgery and individual clinician reports (ICR) from 1st November 2021 for performance monitoring.
This study evaluates the effectiveness of the bundle in reducing LoS and costs without compromising patient safety.METHODS: This was an observational study of all patients undergoing LC from 1st October 2019 to 31st May 2022. Patients were grouped based on the intervention(s) that had been implemented when they had surgery (RO, RO_SSW, RO_SSW_ICR), with LC patients from 1st October 2019 to 30th June 2020 as historical control.
Negative binomial regression and chi-square tests were performed to compare LoS and safety outcomes (i.e., blood transfusion, complication, unplanned readmission, unplanned re-operation (RTOT) and unscheduled biliary intervention within 30 days of index surgery) respectively with the control group. A cost-minimization analysis using a decision tree model was performed to evaluate the cost (hospital stay during index surgery, RTOT and hospital stay due to 30-day readmission after index discharge) reductions by the bundle, followed by probabilistic sensitivity analysis (PSA) using Monte Carlo simulations with 1,000 iterations.RESULTS: There were 1,056 LC patients (mean±SD age, 58±15 years; mean±SD ASA score: 2.1±0.5). Adjusted LoS for RO_SSW and RO_SSW_ICR groups was 19% and 21% shorter than control group (p < 0.05). No statistically significant differences were found for safety outcomes.
PSA shows a cost change of -S$7,246 for 1,000 individuals (Range: -S$228,404 – S$200,000) with the probability that adoption is cost saving is 54.5%.CONCLUSIONS: Systematic changes in service structure and provider behaviors can safely reduce costs and LoS of LC patients.
Code
CO76
Topic
Clinical Outcomes, Economic Evaluation
Topic Subcategory
Clinical Outcomes Assessment, Comparative Effectiveness or Efficacy, Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
No Additional Disease & Conditions/Specialized Treatment Areas, Surgery